glp-1 mounjaro Could Weight Loss Drugs Also Treat or Prevent Chronic Diseases? glp-1 drugs and hashimoto's GLP-1

If you are weighing peptide based approaches against the well known injectables, read our honest side by side comparison of peptides for weight loss versus Ozempic and how a licensed provider weighs each option against your health history and goals

Dis Model Mech (2013) 6(2):44356.10.1242/dmm.010421 145 Rakoff-NahoumSPaglinoJEslami-VarzanehFEdbergSMedzhitovR

Patients taking tirzepatide 10 mg achieved an average of 19.5% weight loss, and patients taking tirzepatide 15 mg achieved an average of 20.9% weight loss

Pioglitazone after Ischemic Stroke or Transient Ischemic Attack

Im pretty sure neither Novo Nordisk (the company behind Ozempic and Wegovy) or Eli Lilly (the manufacturer of Mounjaro and Zepbound) would object to all of us having at least one indication for taking these drugs